Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • BlankningSe vilka börsnoterade bolag som har offentliggjorda korta positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Transkriptioner

Läs transkriptioner från webbsändningar och audiocasts

Transkriptioner

Läs transkriptioner från webbsändningar och audiocasts

Alla regioner
Sverige
Finland
Danmark
Norge
Senaste
Trendande
Följda

Indutrade, Audiocast, Q3'26

Av Inderes2026-10-23 07:30
Indutrade

Ansvarsfriskrivning: Detta är en maskin­genererad transkription och kan innehålla felaktigheter.

Bo Annvik
00:00 - 07:57

Welcome and good morning on our behalf as well. We are glad to present another strong quarter. So let's start with the overall highlights. Demand improved during the quarter for the majority of our companies, with strongest order intake growth for companies with customers in the medtech and pharma area, within energy, and also the engineering industry. Organic growth was plus 6% with all five business areas improving and a book-to-bill ratio above one. Net sales growth was 13%. Due to acquisitions and strong organic sales of 5%. EBITA margin strengthened from 14.6% to 15.3%, and our cash flow increased by 20%. We have been successful on the acquisition side, with 13 acquisitions announced so far this year, and the activity remains at a high level. Looking more specifically at the top-line development, order intake improved in all business areas and the majority of our companies; despite Q3 normally being a weak book-to-bill quarter, it was slightly positive in this quarter at 101%. And this, also despite the high sales level, order backlog is now 11% higher than in the same period last year. However, as noted previously, the order book increasingly consists of longer lead-time orders, reflecting continued strong energy sector demand driven by AI and data center investments. In terms of sales, acquisitions contributed with plus 8%, a sequential improvement from the 6% we had in Q2, and currency movements had no impact in the quarter. The organic development was strong, plus 5%, benefiting from the increased order backlog development of the last quarter. Three out of five business areas strengthened. The EBITA margin strengthened in the quarter with good operational leverage as the main driver in Industrial & Engineering and Infrastructure & Construction. Life science was on a strong level last year, but improved due to margin-accretive acquisitions. Process. Energy and Water had margin improvements in many companies, but due to an increasingly higher share of project deliveries with slightly lower gross margins, the overall EBITA margin for the business area was basically unchanged. Technology and System Solutions has a strong underlying profitability, but continues to be impacted by weak performance in a few project-oriented companies in the UK, as we have talked about before. Sorry, we missed the top-line comments here, so I will take them now instead. Or rather, the organic sales development. Moving to sales per market, the sales development in the Nordics was strong with a broad positive development in many companies and segments, with companies within energy, infrastructure, and process industry contributing positively, fueled by data center buildup in the Nordics. In the rest of Europe, Benelux and the UK. Ireland was flat from last year, but Germany, Switzerland, and Austria were up, mainly due to a broad general engineering improvement, as well as good development for single-use products for pharmaceutical production and companies with customers within energy. North America and Asia also improved, with valve sales for power generation being strong in the US on the back of the booming data center market. Total EBITA increased 19%, corresponding to an EBITA margin of 15.3% compared to 14.6% last year. EBITA margin was positively affected by the organic sales development. Development continued with strong gross margins and margin-accretive acquisitions. There have been continued price increases in many areas during the quarter, especially connected to freight and raw materials, etc. But our companies have done a really good job in passing price increases to the customers and protecting their gross margins. Looking at the sales development per business area, all business areas had organic growth in the quarter. Process, Energy and Water had the strongest growth of plus 6%, benefiting from the large order book buildup. The last quarter saw growth. Within mainly the energy segment, Life Science and Industrial & Engineering had a positive improvement in many companies, countries and segments. The single-use business was the main driver for Life Science, but many MedTech companies also improved; it is encouraging to see a broad improvement in Infrastructure & Construction and Technology & Systems Solutions. Although from somewhat easier comparables. Then we move into acquisitions. So far this year, we have welcomed 13 companies to Indutrade, with a total annual turnover of 2.1 billion SEK. Continuing the successful trend we have had now for over a year. During the quarter, we announced the two add-ons, Dorte Egelund ApS and Albiox Oy, and the electrification specialist Controlin B.V. In the Netherlands. In Q4, we have announced the acquisitions of the two life science companies, Euromed Medical Solution Sp. z.o.o. and Sinmed Sp. z o.o. zo.o. In Poland. We see Poland as an attractive market. It is a large domestic market and one of the fastest-growing economies in the EU, backed by strong funding and supporting industrial modernisation with many family-owned companies that would fit well within our group. We take strategic steps into new markets, and we have done so many times before. In northern Italy, for example, we have established a platform for continued growth in the region. We are now taking a similar approach as we step up our efforts in Poland. We also announced the acquisition of the German company Schraner GmbH in Q4. It is the first acquisition for the infrastructure and construction business area in two years, as focus has been on organic improvements in that area. We are, however, always open for acquisitions when the right opportunity arises, and Schraner is a good example of this. It is a non-cyclical company operating in a highly regulated niche with a strong position in the German fire protection systems market. We have a continued strong pipeline, paving the way for a continued good acquisition pace going forward. The acquired EBITA was on a record-high level in Q3, as can be seen on the graph to the right at 112 million SEK. Also, looking at the EBITDA margin of the acquired companies, it was at a margin-accretive level of 18.3% for the quarter and close to 18% on a rolling 12-month basis. It is good to note that this includes transaction costs, so the underlying margin is even higher. By that, I turn over to Jan Öhman to comment more on our financials.

Jan Öhman
07:58 - 10:29

Thank you. I also want to add some comments to the year-to-date and rolling 12-month numbers for Indutrade. Year to date, order intake is up 10% and net sales 8%, despite a slow start in the first quarter. Book-to-bill was positive also this quarter, giving us a good order backlog. Bookings remained strong as we left the third quarter. Gross margin has improved during the year, which also indicates that our companies have been successful in transferring price increases to our customers. EBITA and EBITA margin were strong, supported by organic sales growth, improved gross margin, and margin-accretive acquisitions. Year to date, we are on a 14.5% EBITA margin and on a rolling 12-month basis at 14.2%, which is also above our financial targets. Return on capital employed improved from 18% in 2025 up to 19%, meaning that we are now closing the gap to our target of 20%. We then continue with the cash flow. We continue to manage our working capital, which remains at stable levels in relation to sales and operating cash flow. Cash flow improved 20% quarter on quarter and amounted to 1.2 billion SEK. SEK. Cash conversion continued to be at high and stable levels and on a rolling 12-month basis, the operating cash flow amounts to 4.3 billion SEK. The interest-bearing net debt declined compared to Q2 when we paid the dividend, but it is up compared to the same period last year due to the increased acquisition pace; we continue to maintain a strong financial position with a net debt-to-equity ratio of 50% and a net debt to EBITDA ratio of 1.6. The tax rate was 22% for the quarter and 23% on a rolling 12-month basis. Finance net increased 23 million SEK, or 23% quarter-on-quarter, mainly as an effect of our high acquisition pace. And last but very important, our earnings per share improved significantly in the quarter, up 19%, and year to date we are up 13% despite the slow start of the year. And it's really satisfying to see that the rolling 12-month trend is moving in the right direction. So with that, I hand it back to you for some final takeaways.

Bo Annvik
10:30 - 11:44

Thank you. So to conclude, strong sales growth in the quarter translated into good bottom line growth; despite the strong net sales, order intake was even higher, resulting in a slightly positive book-to-bill in the quarter and a broad-based improvement in demand. Good operational leverage, continued strong gross margin, and margin-accretive acquisitions drove solid improvements in EBITA and EBITA margin. Looking ahead, we have a larger order backlog and good acquisition momentum, although the backlog is somewhat more weighted towards long-term projects and overall market uncertainty remains high. With 13 acquisitions so far in 2026 and a strong pipeline, we are well positioned to maintain a strong acquisition pace going forward. We continue to meet many of our financial targets in the quarter and remain fully focused on sustaining this momentum going forward. By that, we end our formal presentation and we open up for questions and answers.

Operator
11:47 - 12:04

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial the pound key on your telephone keypad. The next question comes from Max Bosco from SEB. Please go ahead.

Max Bosco
12:06 - 12:29

Thank you and good morning, Bo and Jan. Well done in the quarter. I have three questions, perhaps starting with your comment on longer lead times in parts of the order intake here in the quarter. When looking at the total order book, would you say that you have a good mix of short, medium, and long-term orders in it?

Bo Annvik
12:31 - 13:06

Yes. It is a good mix and it is absolutely not the case that all of the order book consists of long lead times. So, not all of the order book is made up of long lead times, but in certain parts, it is linked to, for example, the energy sector. You can take specifically gas turbines. We support flow equipment into them, and they have a very long order book now. So some of those projects will materialize a bit later. But I would say it's a good mix.

Max Bosco
13:07 - 13:33

Okay. Understood. And then turning to the Life Science segment. I mean, continued good development there, but compared to Q2, it is at least a bit down in organic sales and EBITA growth, albeit at quite high levels in Q2. Would you say that this is a reflection of tougher comparables or something else to it?

Bo Annvik
13:35 - 14:40

It can shift a bit between quarters. There are some project-oriented deliveries. So, I would say that the momentum is equally strong in Q3 as it was in Q2. So, nothing dramatic to build on in that sense; during the first half of the year, the medtech area has been slightly more of a driver than the pharmaceutical area. In Q2 and Q3, the focus has shifted slightly towards the product-related area. But both areas are doing well. I think entering into Q4, the former area and the single-use area will continue in a good way. So, we are quite optimistic in terms of the life science area broadly.

Max Bosco
14:41 - 15:25

Okay. Understood. And then the last question: you touched upon this both in the report and during the presentation, but the Process, Energy and Water segment, as well as the Technology and Systems Solutions segment, show slightly lower profitability year-over-year. For the first segment, you mentioned it is due to a higher proportion of product business. And then for the latter segment, as you have touched upon before, a few project-oriented businesses in the UK are struggling a bit. How long do you foresee this dynamic lasting in the coming quarters as well? What is your thinking on that?

Bo Annvik
15:26 - 17:42

I think we are trending towards some improvement. So I think the situation will improve a little bit in both categories sequentially from Q3 to Q4. But if you take a stereotypical Indutrade company, the majority of the business is usually some sort of day-to-day business delivering into some sort of production system, which needs to replace filters, seals, valves, and things like that on a periodic level. And then when the economy is improving, CapEx is improving and the project business is growing. In general, I would say that the gross margins become a little bit more challenged or are slightly lower in a project growth environment. That is what we have seen in the Process, Energy and Water area to some extent. But I wouldn't say it's dramatic. And I think we also have purchasing costs, raw material costs, and energy costs increasing a bit. They work actively with pricing. I believe they will continue to do that in Q4. So that is why I am sequentially a bit optimistic that the leverage for Process, Energy and Water, which we call it in short, will slightly improve in Q4 versus Q3. Technology and Systems Solutions is working extremely hard with these companies in the UK. It is a transformation. They went into the hydrogen business and now they are pivoting. Transforming back into HVAC and other areas and reestablishing customer relationships and so on. So it is taking some time, but they are taking good steps, and it will not be solved in Q4. But I think we are seeing better and better small steps.

Max Bosco
17:45 - 17:54

Okay. Understood. Thank you very much for the answers. That was all from me. Well done. Goodbye.

Bo Annvik
17:55 - 17:56

Thank you. Thanks a lot.

Operator
17:58 - 18:10

As a reminder, if you wish to ask a question, please dial the pound key on your telephone keypad. The next question comes from Ope Otani from Goldman Sachs. Please go ahead.

Ope Otani
18:11 - 18:41

Hi. Good morning. Good morning Jan. Thanks for taking my question. Two from my end on orders and then on construction. I suppose. Orders have been strong year to date and the book-to-bill ratio is building, as you say. Have there been any changes in terms of how you see the timing of order conversion? Is that sort of still becoming longer because of some of those orders in process and ways in which you might expect orders being released earlier?

Bo Annvik
18:43 - 18:47

Excuse me. Was this in infrastructure and construction?

Ope Otani
18:48 - 18:50

Just across the group.

Bo Annvik
18:51 - 19:41

Yeah. Yeah. There is an order book with a slightly larger content of orders which will be delivered not in Q4 or Q1, but a bit later; however, it is absolutely manageable and it will not impact our organic growth drastically in any way going forward. So, I think it is prudent for us to mention this so that you are aware of this. But I think broadly, it's absolutely a manageable situation. Also, in the short term for us going forward, that answers your question.

Ope Otani
19:41 - 20:01

Yes, that helps. And just on construction, I suppose, plus 3%, which is a notable sequential improvement, is quite good. But what are your thoughts in terms of that end market? Is that just off a low comparable base, or is that due to a slight improvement in demand?

Bo Annvik
20:03 - 20:48

There is a slight improvement in demand. But it is still slight. So, you shouldn't expect too much in terms of organic uptake sequentially or shortly, but they are working diligently with the costs and the gross margin pricing. So, leverage is still strong from those types of activities. But it is a bit of a longer road before we see really strong uptake. I think in project activity on that front. Infrastructure is moving quite well, but the construction area is still a bit weak, I would say.

Ope Otani
20:51 - 20:53

Okay. Thanks for taking my questions.

Bo Annvik
20:53 - 20:54

Thank you so much.

Operator
20:57 - 21:04

There are no more questions at this time. So, I hand the conference back to the speakers for any closing comments.

Bo Annvik
21:05 - 21:12

Then we say thank you from our side. Thank you for listening in, asking good questions, and we wish you a continued pleasant day. Good day.

Till webcasten
Pierce Group, Audiocast, Q3'26
Språk: Engelska2026-11-13 08:00
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Språk: Engelska2026-11-12 10:00
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Språk: Engelska2026-11-12 09:00
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Språk: Engelska2026-11-12 08:00
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Språk: Engelska2026-11-12 08:00
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Språk: Svenska2026-11-12 08:00
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Språk: Engelska2026-11-12 08:00
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Språk: Engelska2026-11-12 07:15
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Språk: Engelska2026-11-11 13:00
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Språk: Engelska2026-11-11 13:00
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Språk: Engelska2026-11-11 12:30
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Språk: Engelska2026-11-11 09:00
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Språk: Engelska2026-11-11 09:00
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Språk: Engelska2026-11-10 17:00
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Språk: Engelska2026-11-10 08:00
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Språk: Engelska2026-11-10 08:00
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Språk: Svenska2026-11-06 09:00
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Språk: Engelska2026-11-06 09:00
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Språk: Engelska2026-11-06 09:00
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Språk: Engelska2026-11-06 09:00
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…